Cardiac Magnetic Resonance Imaging In The Evaluation Of Patients With Valvular Heart Disease. Journal of Pharmaceutical Negative Results, [S. l.], p. 1349–1367, 2023. DOI: 10.47750/pnr.2023.14.02.174. Disponível em: https://www.pnrjournal.com/index.php/home/article/view/7546.. Acesso em: 9 jun. 2026.